Black Belt Therapeutics Limited

Simone Filosto

Bianka Prinz

Anne Goubier

Beatriz Goyenechea Corzo

Josephine Salimu

Kevin Moulder

Pascal Merchiers

Hemanta Baruah

Nina Eissler

The present disclosure provides antibody sequences found in antibodies that bind to human CD38. In particular, the present disclosure provides sequences of anti-human CD38 antibodies. Antibodies and antigen-binding portions thereof including such sequences present features compatible with pharmaceutical manufacturing and development can be provided as fully human antibodies (e.g., fully human monoclonal antibodies or antigen-binding fragments) that can be useful for medical methods and compositions, in particular for treating cancer.

CD38 modulating antibody agents

CD38 modulating antibody

CD38 antibody

The present disclosure provides antibodies that bind to human CD38. In particular, the antibodies and antigen-binding portions thereof are defined by particular functional characteristics. The antibodies present features compatible for manufacturing and can be provided as fully human antibodies (e.g., fully human monoclonal antibodies or antigen-binding fragments) that can be useful for medical methods and compositions, in particular for treating cancer.

Growing community of inventors

Stevenage, United Kingdom

Simone Filosto